HLA-B*5701 and HLA-B*5801 in an Indian patient with anti-epileptics induced cutaneous adverse drug reactions

Eur J Clin Pharmacol. 2019 Apr;75(4):599-601. doi: 10.1007/s00228-018-02618-5. Epub 2019 Jan 4.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Acute Generalized Exanthematous Pustulosis / blood
  • Acute Generalized Exanthematous Pustulosis / etiology
  • Acute Generalized Exanthematous Pustulosis / genetics*
  • Acute Generalized Exanthematous Pustulosis / immunology
  • Alleles
  • Anticonvulsants / adverse effects*
  • Carbamazepine / adverse effects
  • Epilepsy / diagnosis
  • Epilepsy / drug therapy*
  • Genetic Predisposition to Disease
  • HLA-B Antigens / blood*
  • HLA-B Antigens / immunology
  • Humans
  • India
  • Male
  • Middle Aged
  • Phenytoin / adverse effects

Substances

  • Anticonvulsants
  • HLA-B Antigens
  • HLA-B*57:01 antigen
  • HLA-B*58:01 antigen
  • Carbamazepine
  • Phenytoin